Sign in to view content

OTX-TKI for the Treatment of Neovascular Age-related Macular Degeneration 12-Month Results From a US Clinical Trial

Robert L. Avery, MD

Video
Published 2023

Related

Episode 23: CANTREAT Study. Ranibizumab Monthly vs Treat-and-Extend for wAMD with Dr. Peter Kertes
Keyvan Koushan, MD, FRCSC
Member Podcasts
2019
Episode 28: Brolucizumab for wet AMD (HAWK and HARRIER) - Dr. Pravin Dugel
Keyvan Koushan, MD, FRCSC
Member Podcasts
Defining and Addressing Wet AMD Non-responders
Rishi P. Singh, MD
Updates from the Field
2019

Category: AMD-Neovascular

See more